Simon Tarsh
CIK: 0001943931
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 15, 2025ONCO
Onconetix, Inc.
Other(J)Direct39 shares- - Aug 15, 2025ONCO
Onconetix, Inc.
Award(A)Direct618 shares- - Nov 4, 2024RENB
RENOVARO INC.
Award(A)DirectOption to purchase shares of common stock
58.5K shares- - Sep 26, 2024ONCO
Onconetix, Inc.
Award(A)Direct3.3K shares-
1-4 of 4 transactions
About Tarsh Simon
Tarsh Simon (SEC CIK 0001943931) files insider reports with the SEC as Director of Onconetix, Inc. (ONCO) and Interim CFO of RENOVARO INC. (RENB).
Signal8 holds 3 ownership filings by Tarsh Simon, all Form 4s, filed between Sep 30, 2024 and Aug 19, 2025. Those filings report 4 transactions, the latest on Aug 15, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Tarsh Simon's filings is in LOS ANGELES, CA.
Recent filings by Tarsh Simon
Other insiders filing for Onconetix, Inc. (ONCO)
- HRT FINANCIAL LP, 10% Owner
- White David Allan, Chief Executive Officer
- DORF SAMMY, Director
- Romano Sarah, Director
- Oakley Andrew John, Director
- Meier Thomas, Director